Recall Radar
All recallsMedicine & devices

Naropin (ropivacaine hydrochloride Injection, USP), 0.5%, 100 mg per 20 mL (5 mg per mL), Twenty-five, 20 mL Single-Dose Vials, Rx only, Fresenius Kabi, Lake Zurich, IL 60047 NDC…

Presence of Particulate Matter: Hair was found in products

Class II Medicine & devices FDA July 29, 2026 Reached Texas
Read the official FDA notice →

What to do

Stop using the product and check it against the description above. Follow the remedy on the official notice; most recalls are refunded or replaced without a receipt. If you or a family member has already been affected, keep the packaging and the lot code — they're what a claim rests on later.

Details

Recalling company
Fresenius Kabi USA, LLC — Lake Zurich, IL
Severity
Class II — moderate
Reported
July 29, 2026
Quantity
92,600 vials
Recall number
D-0727-2026
Status
Ongoing
Source
FDA

Where it went

Nationwide within in the USA

Other medicine & devices recalls

See every current recall on the live dashboard →